Head-to-head · computed 2026-08-11
MEDVi vs Oak Longevity
MEDVi: MEDVi advertises a $179 semaglutide start that tiers to $299 at maintenance; tirzepatide is $399 flat. Oak Longevity: A small cash-pay telehealth program whose $133/month flat semaglutide price is currently the lowest month-to-month figure in our semaglutide index.
Tirzepatide
Only MEDVi offers tirzepatide ($399 a month billed monthly); Oak Longevity does not, so there is no contest to score.
Semaglutide
| MEDVi | Oak Longevity | |
|---|---|---|
| All-in maintenance | $299/mo | $133/mo |
| Best plan rate | $299/mo | $133/mo |
| 12-month total | $3,588 | $1,596 |
| Status | Provider-stated · 2026-08-05 | Provider-stated · 2026-08-08 |
The arithmetic
On the figures our desk holds, Oak Longevity's $133 a month undercuts MEDVi's $299 by $166 a month at the 2.4 mg/wk maintenance basis — $1,992 across a year. Oak Longevity's figure is provider-stated (captured 2026-08-08) and MEDVi's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
MEDVi's semaglutide ladder runs $299 a month billed monthly. Oak Longevity's runs $133 a month billed monthly. On the twelve-month basis Oak Longevity's $1,596 beats MEDVi's $3,588 by $1,992 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Structure, side by side
MEDVi
- MembershipNone
- Dose policyTiered on semaglutide; tirzepatide flat
- CommitmentMonth-to-month
- CancellationCancel before renewal
- PharmacyPartner pharmacies
Oak Longevity
- MembershipNone
- Dose policyDose-flat (stated)
- CommitmentMonth-to-month
- CancellationCancel before renewal
- PharmacyPartner 503A pharmacy (not publicly itemized)
What our desk is watching on each
MEDVi: Start-vs-maintenance spread on semaglutide; compare on maintenance.
Oak Longevity: Small operator; pharmacy partner not publicly itemized. Price captured from the provider's published pages; checkout capture pending.
Questions people ask
Is MEDVi or Oak Longevity cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does MEDVi vs Oak Longevity miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do MEDVi and Oak Longevity cost over a full year of semaglutide?
On the plans our database holds, a year of semaglutide runs $3,588 at MEDVi and $1,596 at Oak Longevity — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: MEDVi · Oak Longevity. Official sites: MEDVi ↗ · Oak Longevity ↗. Nothing here is medical advice.